Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease.

Literature DB >> 24898744

MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease.

Abstract

MicroRNAs play central roles in cardiovascular disease, and their therapeutic manipulation raises exciting opportunities as well as challenges in the path toward clinical development.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers
MicroRNAs

Year: 2014 PMID： 24898744 PMCID： PMC4279862 DOI： 10.1126/scitranslmed.3009008

Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956

28 in total

Review 1. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

Authors: Esther E Creemers; Anke J Tijsen; Yigal M Pinto
Journal: Circ Res Date: 2012-02-03 Impact factor: 17.367

2. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.

Authors: David M Patrick; Rusty L Montgomery; Xiaoxia Qi; Susanna Obad; Sakari Kauppinen; Joseph A Hill; Eva van Rooij; Eric N Olson
Journal: J Clin Invest Date: 2010-10-18 Impact factor: 14.808

Review 3. MicroRNAs in stress signaling and human disease.

Authors: Joshua T Mendell; Eric N Olson
Journal: Cell Date: 2012-03-16 Impact factor: 41.582

4. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.

Authors: Enzo R Porrello; Brett A Johnson; Arin B Aurora; Emma Simpson; Young-Jae Nam; Scot J Matkovich; Gerald W Dorn; Eva van Rooij; Eric N Olson
Journal: Circ Res Date: 2011-07-21 Impact factor: 17.367

Review 5. Pervasive roles of microRNAs in cardiovascular biology.

Authors: Eric M Small; Eric N Olson
Journal: Nature Date: 2011-01-20 Impact factor: 49.962

6. Atrial natriuretic peptide is negatively regulated by microRNA-425.

Authors: Pankaj Arora; Connie Wu; Abigail May Khan; Donald B Bloch; Brandi N Davis-Dusenbery; Anahita Ghorbani; Ester Spagnolli; Andrew Martinez; Allicia Ryan; Laurel T Tainsh; Samuel Kim; Jian Rong; Tianxiao Huan; Jane E Freedman; Daniel Levy; Karen K Miller; Akiko Hata; Federica Del Monte; Sara Vandenwijngaert; Melissa Swinnen; Stefan Janssens; Tara M Holmes; Emmanuel S Buys; Kenneth D Bloch; Christopher Newton-Cheh; Thomas J Wang
Journal: J Clin Invest Date: 2013-07-15 Impact factor: 14.808

7. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure.

Authors: Ellen Dirkx; Monika M Gladka; Leonne E Philippen; Anne-Sophie Armand; Virginie Kinet; Stefanos Leptidis; Hamid El Azzouzi; Kanita Salic; Meriem Bourajjaj; Gustavo J J da Silva; Servé Olieslagers; Roel van der Nagel; Roel de Weger; Nicole Bitsch; Natasja Kisters; Sandrine Seyen; Yuka Morikawa; Christophe Chanoine; Stephane Heymans; Paul G A Volders; Thomas Thum; Stefanie Dimmeler; Peter Cserjesi; Thomas Eschenhagen; Paula A da Costa Martins; Leon J De Windt
Journal: Nat Cell Biol Date: 2013-10-27 Impact factor: 28.824

8. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts.

Authors: Jinghai Chen; Zhan-Peng Huang; Hee Young Seok; Jian Ding; Masaharu Kataoka; Zheng Zhang; Xiaoyun Hu; Gang Wang; Zhiqiang Lin; Si Wang; Willam T Pu; Ronglih Liao; Da-Zhi Wang
Journal: Circ Res Date: 2013-04-10 Impact factor: 17.367

9. Inhibition of miR-25 improves cardiac contractility in the failing heart.

Authors: Christine Wahlquist; Dongtak Jeong; Agustin Rojas-Muñoz; Changwon Kho; Ahyoung Lee; Shinichi Mitsuyama; Alain van Mil; Woo Jin Park; Joost P G Sluijter; Pieter A F Doevendans; Roger J Hajjar; Mark Mercola
Journal: Nature Date: 2014-03-12 Impact factor: 49.962

Review 10. Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication.

Authors: Virginie Kinet; Julie Halkein; Ellen Dirkx; Leon J De Windt
Journal: Front Genet Date: 2013-11-12 Impact factor: 4.599

103 in total

1. Mir-351-5p contributes to the establishment of a pro-inflammatory environment in the H9c2 cell line by repressing PTEN expression.

Authors: Walmir da Silva; Robson Augusto Souza dos Santos; Karen C M Moraes
Journal: Mol Cell Biochem Date: 2015-11-05 Impact factor: 3.396

9. Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development.

Authors: Nathan L Price; Noemi Rotllan; Xinbo Zhang; Alberto Canfrán-Duque; Timothy Nottoli; Yajaira Suarez; Carlos Fernández-Hernando
Journal: Circ Res Date: 2019-03-15 Impact factor: 17.367

Review 10. Emerging Biosensing Approaches for microRNA Analysis.

Authors: Richard M Graybill; Ryan C Bailey
Journal: Anal Chem Date: 2015-12-21 Impact factor: 6.986

MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease.

Review 1. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

2. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.

Review 3. MicroRNAs in stress signaling and human disease.

4. MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.

Review 5. Pervasive roles of microRNAs in cardiovascular biology.

6. Atrial natriuretic peptide is negatively regulated by microRNA-425.

7. Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure.

8. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts.

9. Inhibition of miR-25 improves cardiac contractility in the failing heart.

Review 10. Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication.

1. Mir-351-5p contributes to the establishment of a pro-inflammatory environment in the H9c2 cell line by repressing PTEN expression.

Review 2. Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Review 3. Long noncoding RNAs in cardiac development and ageing.

4. A H(a)rd Way to Adapt in Cardiac Hypertrophy.

5. MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.

Review 6. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.

Review 7. Muscle as a "mediator" of systemic metabolism.

Review 8. The role of miRNAs in cardiovascular disease risk factors.

9. Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development.

Review 10. Emerging Biosensing Approaches for microRNA Analysis.